Lista de obras - Kamila Wojas-Krawczyk - Dominio Público Uruguay

A Chemometry of <i>Aldrovanda vesiculosa</i> L. (Waterwheel, Droseraceae) Populations

artículo científico publicado en 2020

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

artículo científico publicado en 2019

Aptamers in Non-Small Cell Lung Cancer Treatment

scientific article published on 09 July 2020

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

scientific article published on 03 November 2019

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease

artículo científico publicado en 2017

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

artículo científico publicado en 2019

Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation

scientific article published on 01 August 2003

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

artículo científico publicado en 2017

Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.

artículo científico publicado en 2015

Dendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patway

artículo científico publicado en 2016

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies

artículo científico publicado en 2015

Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients

article

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.

scientific article published on 27 July 2013

EGFR gene mutations in patients with adenosquamous lung carcinoma.

artículo científico publicado en 2014

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients-Literature Review

artículo científico publicado en 2020

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique.

artículo científico publicado en 2017

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

scientific article published on 16 November 2020

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.

artículo científico publicado en 2017

Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report

scientific article published on 06 December 2011

Imperfect Predictors for Lung Cancer Immunotherapy-A Field for Further Research

artículo científico publicado en 2020

In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka

artículo científico publicado en 2017

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.

artículo científico publicado en 2012

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

artículo científico publicado en 2014

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

scientific article published on 08 June 2019

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report

artículo científico publicado en 2008

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

artículo científico publicado en 2014

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer

artículo científico publicado en 2016

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene

artículo científico publicado en 2013

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

artículo científico publicado en 2013

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study

artículo científico publicado el 24 de abril de 2012

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

artículo científico publicado en 2015

Preventing central nervous system metastases in non-small cell lung cancer

artículo científico publicado en 2018

Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.

artículo científico publicado en 2012

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report

artículo científico publicado en 2014

Remission of advanced EGFR-positive lung adenocarcinoma after short and intermittent erlotinib therapy.

artículo científico publicado en 2015

Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer

artículo científico publicado en 2016

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

scientific article published on 19 December 2013

The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.

artículo científico publicado en 2011

The application of real-time PCR technique to detect rare cell clones with primary T790M Substitution of EGFR gene in metastases of non-small cell lung cancer to central nervous system in chemotherapy naive patients.

artículo científico publicado en 2014

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

artículo científico publicado en 2014

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.

artículo científico publicado en 2013

The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.

artículo científico publicado en 2012

The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors

artículo científico publicado en 2012

Toxicity of Carlina Oxide-A Natural Polyacetylene from the Carlina acaulis Roots-In Vitro and In Vivo Study

scientific article published on 09 April 2020

[Evaluation of Th1/Th2 lymphocyte balance and lipopolysaccharide receptor expression in asthma patients]

scientific article published on 01 January 2009

Lista de obras de Kamila Wojas-Krawczyk

A Chemometry of <i>Aldrovanda vesiculosa</i> L. (Waterwheel, Droseraceae) Populations

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

Aptamers in Non-Small Cell Lung Cancer Treatment

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.

Dendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patway

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies

Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.

EGFR gene mutations in patients with adenosquamous lung carcinoma.

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients-Literature Review

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique.

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.

Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report

Imperfect Predictors for Lung Cancer Immunotherapy-A Field for Further Research

In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

Preventing central nervous system metastases in non-small cell lung cancer

Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report

Remission of advanced EGFR-positive lung adenocarcinoma after short and intermittent erlotinib therapy.

Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.

The application of real-time PCR technique to detect rare cell clones with primary T790M Substitution of EGFR gene in metastases of non-small cell lung cancer to central nervous system in chemotherapy naive patients.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.

The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.

The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors

Toxicity of Carlina Oxide-A Natural Polyacetylene from the Carlina acaulis Roots-In Vitro and In Vivo Study

[Evaluation of Th1/Th2 lymphocyte balance and lipopolysaccharide receptor expression in asthma patients]